63 related articles for article (PubMed ID: 38481389)
1. An Evaluation of the Health Economics of Postnatal Depression Prevention and Treatment Strategies in China: A Cost-Effectiveness Analysis.
Zheng Z; Feng T; Xu J; Zhang X; Yu X
Healthcare (Basel); 2024 May; 12(11):. PubMed ID: 38891150
[TBL] [Abstract][Full Text] [Related]
2. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
3. Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis.
Zhou H; Yan M; Che D; Wu B
JHEP Rep; 2024 Apr; 6(4):101000. PubMed ID: 38481389
[TBL] [Abstract][Full Text] [Related]
4. Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Deuffic-Burban S; Huneau A; Verleene A; Brouard C; Pillonel J; Le Strat Y; Cossais S; Roudot-Thoraval F; Canva V; Mathurin P; Dhumeaux D; Yazdanpanah Y
J Hepatol; 2018 Oct; 69(4):785-792. PubMed ID: 30227916
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
6. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.
Kim HL; Kim KA; Choi GH; Jang ES; Ki M; Choi HY; Jeong SH
Clin Mol Hepatol; 2022 Jan; 28(1):91-104. PubMed ID: 34736311
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection.
Zhou HJ; Wu G; Li JM; Naidoo N; Xie YX; Feng BL; Wang P; Luo JW
Ann Palliat Med; 2021 Oct; 10(10):10313-10326. PubMed ID: 34670381
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness of HCV testing strategies for hepatitis C elimination in general population in China].
Liu PC; Xu D; Ding GW; Zhao L; Yu JJ; Liu ZF; Li J
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Mar; 45(3):464-472. PubMed ID: 38514325
[No Abstract] [Full Text] [Related]
9. Interpretation of the National Action Plan for Eliminating Hepatitis C as a Public Health Threat (2021-2030).
Li J; Pang L; Liu Z
China CDC Wkly; 2022 Jul; 4(29):627-630. PubMed ID: 35919827
[TBL] [Abstract][Full Text] [Related]
10. Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China.
Song Y; Li Y; Cheng H; Du X; Mi J; Le LV; Chen Z; Chan P; Sun J
Infect Dis Ther; 2022 Aug; 11(4):1427-1442. PubMed ID: 35821355
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis.
Xie J; Xu B; Wei L; Huang C; Liu W
Infect Dis Ther; 2022 Aug; 11(4):1661-1682. PubMed ID: 35749010
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Hepatitis C Elimination in China: From Epidemiology, Natural History, and Intervention Perspectives.
Zhao Z; Chu M; Guo Y; Yang S; Abudurusuli G; Frutos R; Chen T
Front Microbiol; 2022; 13():884598. PubMed ID: 35722351
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis.
Tang W; Tao Y; Fajardo E; Reipold EI; Chou R; Tucker JD; Easterbrook P
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626411
[TBL] [Abstract][Full Text] [Related]
14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E; Mauskopf J; Mullins CD; Petrou S; Pwu RF; Staniszewska S
Value Health; 2022 Jan; 25(1):10-31. PubMed ID: 35031088
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
